FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 114 filers reported holding FURIEX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $12,893,000 | +22.0% | 121,432 | 0.0% | 0.01% | +12.5% |
| Q1 2014 | $10,565,000 | +90.1% | 121,432 | -8.2% | 0.01% | +100.0% |
| Q4 2013 | $5,558,000 | -19.5% | 132,311 | -15.7% | 0.00% | -33.3% |
| Q3 2013 | $6,903,000 | +22.2% | 156,922 | -5.4% | 0.01% | +20.0% |
| Q2 2013 | $5,651,000 | – | 165,863 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 319,536 | $13,424,000 | 9.48% |
| Global Alpha Capital Management Ltd. | 67,120 | $2,996,000 | 4.61% |
| Consonance Capital Management LP | 648,829 | $27,257,000 | 4.47% |
| Alistair Capital Management, L.L.C. | 168,738 | $7,089,000 | 3.18% |
| Artal Group S.A. | 870,842 | $36,584,000 | 1.31% |
| Breithorn Capital Management | 48,058 | $2,019,000 | 1.13% |
| THOMPSON SIEGEL & WALMSLEY LLC | 600,615 | $25,232,000 | 0.59% |
| FRANKLIN STREET ADVISORS INC /NC | 52,325 | $2,198,000 | 0.44% |
| Visium Asset Management, LP | 312,698 | $13,136,000 | 0.26% |
| AMERICAN CAPITAL MANAGEMENT INC | 49,134 | $2,064,000 | 0.26% |